tiprankstipranks
Seelos Therapeutics (SEELQ)
OTHER OTC:SEELQ
US Market

Seelos Therapeutics (SEELQ) Income Statement

Compare
1,210 Followers

Seelos Therapeutics Income Statement

Last quarter (Q2 2024), Seelos Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Seelos Therapeutics's net income was $1.71M. See Seelos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 2.20M$ ―$ ―$ ―$ 151.00K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -37.75M$ -73.47M$ -64.45M$ -18.94M$ -51.23M
Operating Income
$ -40.50M$ -70.92M$ -61.67M$ -18.76M$ -34.99M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -37.88M$ -73.53M$ -66.05M$ -19.10M$ -51.26M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Seelos Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis